Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.62 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9517306 | 0.94 | DGKA (0.56) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL3918716 | 0.94 | DGKA (0.56) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL2193854 | 0.94 | DGKA (0.56) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL3927345 | 0.89 | DGKA (0.50) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL9637091 | 0.89 | DGKA (0.65) | DGKAPRSS1PRSS2PRSS3NAAA | |
| Cetyl Palmitate SCHEMBL8815494 | 0.89 | DGKA (0.65) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL8815475 | 0.89 | DGKA (0.65) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL8359802 | 0.87 | DGKA (0.62) | DGKAPRSS1PRSS2PRSS3NAAA | |
| Cetyl Palmitate SCHEMBL7134252 | 0.87 | DGKA (0.62) | DGKAPRSS1PRSS2PRSS3NAAA | |
| SCHEMBL8820849 | 0.87 | DGKA (0.62) | DGKAPRSS1PRSS2PRSS3NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173099-A1 | LIPOLYSIS COMPOSITION USING SURFACE-MODIFIED GAS-GENERATING NANOPARTICLES | SUPERNOVA BIO CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | AE KYUNG INDUSTRIAL CO., LTD. (KR) | 2022-12-06 | — | — | US | disclosed |
| CN-115297880-A | Topical composition comprising extract of crude drug comprising arillus longan for treating or improving skin ulcer, and its application | (株)美迪合伙来音 | 2022-11-04 | — | — | CN | disclosed |
| CN-115297879-A | Topical composition comprising arillus longan combined crude drug extract for regenerating skin and treating or improving skin wound, and its application | (株)美迪合伙来音 | 2022-11-04 | — | — | CN | disclosed |
| CN-115279387-A | Topical composition comprising arillus longan combined crude drug extract for inhibiting TSLP and treating or improving skin inflammation diseases, and its application | (株)美迪合伙来音 | 2022-11-01 | — | — | CN | disclosed |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2020-11-12 | — | — | US | disclosed |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20190133989-A1 | ANTIMICROBIAL COMPOSITION CONTAINING 7,10-EPOXYOCTADECA-7,9-DIENOIC ACID AS ACTIVE INGREDIENT | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2019-05-09 | — | — | US | disclosed |
| US-10233143-B2 | Pseudoceramide compound, and external use skin preparation composition containing same | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20170313648-A1 | NOVEL PSEUDOCERAMIDE COMPOUND, AND EXTERNAL USE SKIN PREPARATION COMPOSITION CONTAINING SAME | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20090030100-A1 | FINE PORE FORMATION AGENT FOR POROUS RESIN FILM AND COMPOSITION CONTAINING THE SAME FOR POROUS RESIN FILM | MARUO CALCIUM CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1985650-A1 | MICROPORE FORMING AGENT FOR POROUS RESIN FILM AND COMPOSITION FOR POROUS RESIN FILM CONTAINING THE AGENT | MARUO CALCIUM COMPANY LIMITED (JP) | 2008-10-29 | — | — | EP | disclosed |
| CN-101291679-A | Compositions comprising actinidia and methods of use thereof | EFFICAS INC PANGENOMICS CO LTD (US) | 2008-10-22 | — | — | CN | disclosed |
| US-20080182933-A1 | useful for a light reflector of, for example, a liquid crystal display and a lighting apparatus; diaphragm (separator) between electrodes of a battery | MARUO CALCIUM COMPANY LIMITED (JP) | 2008-07-31 | — | — | US | disclosed |
| CN-1960698-A | Local slimming preparation and cosmetic containing carnitine derivative | SHOWA DENKO KK (JP) | 2007-05-09 | — | — | CN | disclosed |
| CN-1297266-C | Stabilized ascorbic acid derivatives | SHOWA DENKO KK (JP) | 2007-01-31 | — | — | CN | disclosed |
| CN-1678333-A | Composition containing extract of actinidia arguta and related species for preventing and treating allergic diseases and non-allergic inflammatory diseases | PANGENOMICS CO LTD (KR) | 2005-10-05 | — | — | CN | disclosed |
| CN-1658864-A | Stabilized ascorbic acid derivatives | SHOWA DENKO KK (JP) | 2005-08-24 | — | — | CN | disclosed |
| CN-1197542-C | Cosmetics | KYOWA HAKKO KOGYO KK (JP) | 2005-04-20 | — | — | CN | disclosed |
| CN-1328813-A | Cosmetics | KYOWA HAKKO KOGY CO LTD (JP) | 2002-01-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | CERS2, ASAH2, ASAH1 | DGKA 193/4885PRSS1 671/4885PRSS2 1912/4885 |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | CERS2, ASAH2, CERT1 | DGKA 214/4885PRSS1 544/4885PRSS2 1673/4885 |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | CYP51A1, IL17A, ELOVL5 | DGKA 73/4885PRSS1 3084/4885PRSS2 3643/4885 |
| US-20190133989-A1 | ANTIMICROBIAL COMPOSITION CONTAINING 7,10-EPOXYOCTADECA-7,9-DIENOIC ACID AS ACTIVE INGREDIENT | CYP51A1, IL17A, ELOVL5 | DGKA 73/4885PRSS1 3084/4885PRSS2 3643/4885 |
| US-20170313648-A1 | NOVEL PSEUDOCERAMIDE COMPOUND, AND EXTERNAL USE SKIN PREPARATION COMPOSITION CONTAINING SAME | CERS2, CERT1, ACER2 | DGKA 453/4885PRSS1 320/4885PRSS2 594/4885 |
| US-10233143-B2 | Pseudoceramide compound, and external use skin preparation composition containing same | CERS2, CERT1, ACER2 | DGKA 572/4885PRSS1 395/4885PRSS2 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.